N
Centralnervesystemet
Parkinsons sygdom
Antiparkinsonmidler
Levodopa kombineret med decarboxylasehæmmer
MAO-B-hæmmere
COMT-hæmmere
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
Dopaminagonister
Antikolinerge midler
Amantadin
Levodopa, decarboxylasehæmmer og COMT-hæmmer i kombination
N04BA
Revideret: 27.11.2024
Karen Østergaard (Forfatter),
Dansk Neurologisk Selskab
Tove Henriksen (Referent),
Dansk Selskab for Bevægeforstyrrelser
Indledning | Anvendelsesområder | Behandlingsvejledning | Præparatvalg | Doseringsforslag | Nedsat lever- og/eller nyrefunktion | Kontraindikationer | Forsigtighedsregler | Patientsikkerhed | Bivirkninger | Interaktioner | Graviditet | Amning | Forgiftning | Farmakodynamik | Farmakokinetik | Tilskud | Præparater | Referencer
Der henvises i øvrigt også til Levodopa kombineret med decarboxylasehæmmer og COMT-hæmmere for en oversigt over præparater med indholdsstofferne hver for sig.
For yderligere oplysninger om behandling af Parkinsons sygdom, se antiparkinsonmidler.
Præparater
| Indholdsstof | Navn og firma | Dispform og styrke | Pakning | Pris enh. | Pris DDD |
|---|---|---|---|---|---|
| Carbidopa Entacapon Levodopa |
Corbilta Orion Pharma
|
filmovertrukne tabletter 200 mg+50 mg+200 mg | 100 stk. (Nordic Prime) | 1,95 | 4,40 |
| Carbidopa Entacapon Levodopa |
Lecigon® Nordic Infucare
|
enteralgel 20+5+20 mg/ml | 7 x 47 ml | 23,55 | 529,96 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 100 stk. | 1,71 | 15,37 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 50+12,5+200 mg | 130 stk. | 3,37 | 30,29 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | 3,08 | 18,48 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | 9,12 | 54,74 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 1,94 | 8,73 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 3,10 | 13,93 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk | 4,21 | 15,14 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | 9,48 | 34,14 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk | 2,59 | 7,78 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 4,61 | 13,83 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. | 1,94 | 4,37 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 130 stk. | 11,82 | 26,60 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Orion" Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 100 stk | 4,62 | 11,88 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Rivopharm" SanoSwiss
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. | 3,10 | 18,63 |
| Carbidopa Entacapon Levodopa |
Levodopa/Carbidopa/Entacapone "Rivopharm" SanoSwiss
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. | 4,16 | 14,99 |
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. | 2,29 | 10,31 |
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | 3,11 | 13,98 |
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. | 2,60 | 7,80 |
| Carbidopa Entacapon Levodopa |
Pentiro STADA Nordic
|
filmovertrukne tabletter 150+37,5+200 mg | 130 stk. | 4,62 | 13,86 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (Orifarm) | 2,12 | 9,54 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (Medartuum) | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 100 stk. (2care4) | 2,20 | 9,89 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 100+25+200 mg | 130 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. (Orifarm) | 3,10 | 9,30 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 150+37,5+200 mg | 100 stk. (Medartuum) | 2,81 | 8,42 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (Orifarm) | 2,30 | 5,18 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (Medartuum) | 2,10 | 4,72 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 200+50+200 mg | 100 stk. (2care4) | 2,02 | 4,54 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 100 stk. (2care4) | 3,13 | 18,75 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 75+18,75+200 mg | 130 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk. (Ebb Medical) | 4,13 | 14,86 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 100 stk.( 2care4) | 3,92 | 14,12 |
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 125+31,25+200 mg | 130 stk. | ||
| Carbidopa Entacapon Levodopa |
Stalevo® Orion Pharma
|
filmovertrukne tabletter 175+43,75+200 mg | 130 stk. |
Referencer
1563. Stocchi F, Rascol O, Kieburtz K et al. Initiating levodopa/carbidopa therapy with and without entacapone in early Parkinson disease: the STRIDE-PD study. Ann Neurol. 2010; 68(1):18-27, https://pubmed.ncbi.nlm.nih.gov/20582993/ (Lokaliseret 10. december 2021)
4678. Stoessl AJ. Continuous dopaminergic therapy in Parkinson disease: time to stride back?. Ann Neurol. 2010; 68:3-5, https://www.ncbi.nlm.nih.gov/pubmed/20583222 (Lokaliseret 17. oktober 2023)
